Correction to: Effects of eculizumab treatment on quality of life in patients with paroxysmal nocturnal hemoglobinuria in Japan

被引：0
|
作者：
Yasutaka Ueda
Naoshi Obara
Yuji Yonemura
Hideyoshi Noji
Masayoshi Masuko
Yoshinobu Seki
Katsuya Wada
Takahisa Matsuda
Hirozumi Akiyama
Takayuki Ikezoe
Shigeru Chiba
Yoshinobu Kanda
Tatsuya Kawaguchi
Tsutomu Shichishima
Hideki Nakakuma
Shinichiro Okamoto
Jun-ichi Nishimura
Yuzuru Kanakura
Haruhiko Ninomiya
机构：
[1] Osaka University Graduate School of Medicine,Department of Hematology and Oncology
[2] Japan PNH Study Group,Department of Hematology
[3] University of Tsukuba,Department of Transfusion Medicine and Cell Therapy
[4] Kumamoto University Hospital,Department of Hematology
[5] Fukushima Medical University,Department of Stem Cell Transplantation
[6] Niigata University Hospital,Department of Hematology
[7] Niigata Prefectural Shibata Hospital,Department of Hematology, Uonuma Institute of Community Medicine
[8] Niigata University Medical and Dental Hospital,Department of Hematology
[9] Matsushita Memorial Hospital,Department of Hematology, Faculty of Medicine
[10] Alexion Pharma G.K,Division of Hematology
[11] University of Tsukuba,Departments of Hematology and Infectious Diseases
[12] Jichi Medical University,Division of Hematology, Department of Medicine
[13] Kumamoto University,Department of Medical Sciences, Faculty of Medicine
[14] Kagoshima Tokusyukai Hospital,undefined
[15] Keio University School of Medicine,undefined
[16] University of Tsukuba,undefined
来源：
International Journal of Hematology | 2018年 / 108卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In the original publication of this article, Tables 2, 3 and 4 were published incorrectly. The corrected tables 2, 3 and 4 are given in the following pages.
引用
收藏
页码：233 / 235
页数：2
相关论文
共 50 条
  • [41] Effect of eculizumab administrations on the haemostatic changes in patients with paroxysmal nocturnal hemoglobinuria
    Seregina, E.
    Nikulina, O.
    Tsvetaeva, N.
    Balandina, A.
    Ataullakhanov, F.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 836 - 836
  • [42] Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria
    Hillmen, Peter
    Muus, Petra
    Duhrsen, Ulrich
    Risitano, Antonio M.
    Schubert, Jorg
    Luzzatto, Lucio
    Schrezenmeier, Hubert
    Szer, Jeffrey
    Brodsky, Robert A.
    Hill, Anita
    Socie, Gerard
    Bessler, Monica
    Rollins, Scott A.
    Bell, Leonard
    Rother, Russell P.
    Young, Neal S.
    [J]. BLOOD, 2007, 110 (12) : 4123 - 4128
  • [43] Ten Years of Clinical Experience With Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria
    de Fontbrune, Flore Sicre
    de latour, Regis Peffault
    [J]. SEMINARS IN HEMATOLOGY, 2018, 55 (03) : 124 - 129
  • [44] Assessing complement blockade in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab
    de Latour, Regis Peffault
    Fremeaux-Bacchi, Veronique
    Porcher, Raphael
    Xhaard, Alienor
    Rosain, Jeremie
    Castaneda, Diana Cadena
    Vieira-Martins, Paula
    Roncelin, Stephane
    Rodriguez-Otero, Paula
    Plessier, Aurelie
    de Fontbrune, Flore Sicre
    Abbes, Sarah
    Robin, Marie
    Socie, Gerard
    [J]. BLOOD, 2015, 125 (05) : 775 - 783
  • [45] Effect of eculizumab therapy on the coagulation status of patients with paroxysmal nocturnal hemoglobinuria
    Gribkova, I
    Tsvetaeva, N.
    Seregina, E.
    Nikulina, O.
    Balandina, A.
    Gorbatenko, A.
    Sinauridze, E.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 : 13 - 13
  • [46] Norm-based comparison of the quality-of-life impact of ravulizumab and eculizumab in paroxysmal nocturnal hemoglobinuria
    Carolyn E. Schwartz
    Roland B. Stark
    Katrina Borowiec
    Sandra Nolte
    Karl-Johan Myren
    [J]. Orphanet Journal of Rare Diseases, 16
  • [47] Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no-treatment study
    Loschi, Michael
    Porcher, Raphael
    Barraco, Fiorenza
    Terriou, Louis
    Mohty, Mohamad
    de Guibert, Sophie
    Mahe, Beatrice
    Lemal, Richard
    Dumas, Pierre-Yves
    Etienne, Gabriel
    Jardin, Fabrice
    Royer, Bruno
    Bordessoule, Dominique
    Rohrlich, Pierre Simon
    Fornecker, Luc Mathieu
    Salanoubat, Celia
    Maury, Sebastien
    Cahn, Jean-Yves
    Vincent, Laure
    Sene, Thomas
    Rigaudeau, Sophie
    Nguyen, Stephanie
    Lepretre, Anne-Claire
    Mary, Jean-Yves
    Corront, Bernadette
    Socie, Gerard
    de Latour, Regis Peffault
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (04) : 366 - 370
  • [48] Norm-based comparison of the quality-of-life impact of ravulizumab and eculizumab in paroxysmal nocturnal hemoglobinuria
    Schwartz, Carolyn E.
    Stark, Roland B.
    Borowiec, Katrina
    Nolte, Sandra
    Myren, Karl-Johan
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
  • [49] Paroxysmal nocturnal hemoglobinuria therapy with eculizumab: Spanish experience
    Lopez Rubio, Montserrat
    Morado, Marta
    Gaya, Ana
    Alonso Rosa, Dora
    Ojeda, Emilio
    Antonio Munoz, Juan
    Perez de Mendiguren, Begona
    Dolores Monteagudo, Maria
    Maria Duran, Jose
    Maria Fisac, Rosa
    Moreno, Damian
    Maria Villegas, Ana
    [J]. MEDICINA CLINICA, 2011, 137 (01): : 8 - 13
  • [50] Predictors of Response to Eculizumab Therapy in Paroxysmal Nocturnal Hemoglobinuria
    DeZern, Amy E.
    Dorr, Donna
    Brodsky, Robert A.
    [J]. BLOOD, 2012, 120 (21)
12345